Community-Acquired Pneumonia

The Harrison's Practice Preview allows you to view 5 FREE complete topics or conduct a search that delivers abstracts for more than 450 medical topics.

For full access, please subscribe today!

Treatment Approach

  • Site of care: 3-step process recommended in IDSA guidelines (2003)
    • Assessment of preexisting conditions that compromise safety of home care (e.g., baseline cognitive function, coexisting conditions, hemodynamic instability, ability to take oral medications)
    • Calculation of the pneumonia PORT (Pneumonia Outcomes Research Team) Severity Index (PSI)
      • Risk classes are based on age, gender, place of residence (nursing home or not), coexisting illness, physical examination findings, and laboratory/radiographic data.
      • Algorithm to calculate score: http://www.chestx-ray.com/Practice/PORT/PORT.html
      • Home care is recommended for patients in risk classes I, II, and III.
      • Patients in risk class IV or V generally should be admitted to the hospital.
    • Clinical judgment: other factors suggesting the need for inpatient treatment
      • Older age (especially when patients are nursing home residents)
      • Social issues (e.g., homelessness, substance abuse) that may compromise outpatient recovery
      • Respiratory rate of > 28/min
      • Systolic blood pressure of < 90 mmHg or 30 mmHg below baseline
      • Altered mental status
      • Hypoxemia: PO2 of < 60 mmHg while patient is breathing room air or oxygen saturation of < 90%
      • Unstable comorbid illness (e.g., decompensated congestive heart failure, uncontrolled diabetes mellitus, alcoholism, immunosuppression)
      • Multilobar pneumonia, if hypoxemia is present
      • Pleural effusion that is > 1 cm on lateral decubitus chest x-ray and has the characteristics of a complicated parapneumonic effusion on pleural fluid analysis
  • Antibiotic therapy
    • Factors that lower the mortality rate include:
      • Antibiotic administration within 8 h of arrival in the emergency room
      • Use of ≥ 2 agents in bacteremic pneumococcal pneumonia
    • Guidelines recommend empirical treatment based on:
      • Likely pathogens
      • Clinical trials showing efficacy of agents
      • Risk factors for antimicrobial resistance (e.g., age > 65 years, β-lactam therapy within the past 3 months, alcoholism, immunosuppressive illness, multiple medical comorbidities, exposure to a child in a day-care center)
      • Medical comorbidities (may influence the likelihood of a specific pathogen’s involvement and contribute to clinical failure)
      • Severity of illness (inpatient vs. outpatient treatment, medical ward vs. ICU care)
    • IV antibiotics can be switched to oral agents when:
      • The WBC count is returning toward normal.
      • Two temperature readings taken 16 h apart are normal.
      • The patient’s clinical condition has improved and the patient can take oral medications with adequate absorption.
  • Other issues
    • Assess risk of aspiration.
    • Counsel about smoking cessation.
    • Assess vaccination status (influenza, pneumococcus).
    • Consider end-of-life decision making.
    • Optimize immune function if the patient is immunosuppressed.

The Harrison's Practice Preview allows you to view 5 FREE complete topics or conduct a search that delivers abstracts for more than 450 medical topics.

For full access, please subscribe today!

Content Manager
Display all Sections
Save To Archive
Related Content
Pneumonia
Pulmonary Edema
Miscellaneous Gram-Negative Bacterial Infections
Lung Abscesses and Empyema

more ...